Latest News & Updates of Loncom Pharma

Biocom made a prominent appearance at the Russia Pharmtech Expo, showcasing its full-industry-chain capabilities and high-end API products, and reached preliminary cooperation intentions with clients across Eurasia. The team conducted in-depth research on the local industry ecosystem and assessed potential production bases, laying the groundwork for deeper regional collaboration and expansion into the Eurasian market. The company remains committed to driving high-quality development in the global pharmaceutical industry through innovation and quality excellence.

Celebrating Shandong Loncom Pharmaceutical's Fezolinetant and Dotinurad Receiving WC Certificates

Shandong Loncom, proudly announces the launch of three high-potential star products: Abrocitinib, Ritlecitinib Mesylate, and Iptacopan (For Research Use Only).

Recently, the Biocom team traveled to Seoul, South Korea, to participate in CPHI Korea 2025, the World Pharmaceutical Ingredients Exhibition. During the event, the team engaged with global pharmaceutical industry leaders to explore collaborative opportunities.